Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01516177 · ClinicalTrials.gov registry record

Associating Renal Transplantation With the ITN Signature of Tolerance

A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
250
Enrollment target

NCT01516177: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

NCT01516177 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01516177 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
250 participants
Enrollment target

Study Summary

This is an observational study for people who have received a kidney transplant within the past 1 to 5 years. Researchers in this study are looking for a certain pattern of genes and cells in the blood that has been found in a group of rare transplant patients who do not need immunosuppression. The study goal is to find out how common this pattern is in transplant patients, as a first step in determining if it can be used to personalize anti-rejection drug regimens better.

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2010-09
Est. Completion 2014-04

What the finished NCT01516177 record still lists

NCT01516177 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01516177 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01516177 about?

NCT01516177 is a clinical study titled "Associating Renal Transplantation With the ITN Signature of Tolerance". This is an observational study for people who have received a kidney transplant within the past 1 to 5 years. Researchers in this study are looking for a certain pattern of genes and cells in the blood that has been found in a group of rare transplant patients who do not need immunosuppression. The ...

What is the current status of trial NCT01516177?

This trial is currently completed. The enrollment target is 250 participants. The study started on 2010-09. Estimated completion is 2014-04.

Who is sponsoring clinical trial NCT01516177?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01516177, the US trial registry maintained by the National Library of Medicine. NCT01516177 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.